Home / Inspections / 1203822

FDA Inspection 1203822 — Mary Bird Perkins Cancer Center

Mary Bird Perkins Cancer Center — FEI 3005551893

The FDA completed an inspection of Mary Bird Perkins Cancer Center on April 25, 2023 in Hammond, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 25, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Hammond, LA (United States)

Facility

Other inspections at this facility

  • 1273734 (NAI Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1096563 (NAI Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987061 (NAI Thu Oct 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 891186 (NAI Thu Aug 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 810072 (NAI Thu Nov 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources